Agenda
17:00 (BST)
Mohamad Mohty
Welcome and introductions
- Introduction to the GvHD Hub
- Satellite symposium educational objectives and pre-activity test
- Introduction to the speakers
17:05 (BST)
Daniel Wolff
Early treatment strategies for SR-GvHD
- A review of current therapeutic strategies for SR-GvHD and treatment guidelines
- The importance of early detection of GvHD, including inflammation and fibrosis
- How early treatment of SR-GvHD is approached in clinical practice, and how this may vary from guidelines
- The impact of early treatment switching and escalation on long-term outcomes
17:30 (BST)
Mohamad Mohty
The importance of real-world data
- An overview of current real-world data and ongoing studies in SR-GvHD (including efficacy and safety findings)
- How real-world evidence can supplement guidelines to inform treatment decisions
- Case-based discussion: Interactive discussion, using case studies, focusing on treatment selection
18:00 (BST)
Steven Pavletic
Quality of life in GvHD
- An overview of QoL assessment tools and the current utilization of these in clinical practice vs clinical trials
- Panel discussion: How to incorporate QoL into GvHD treatment sequencing to ensure optimal outcomes for patients
Learning objectives
After attending this webinar, learners will be able to:
- Describe novel therapeutic targets in GvHD and explain the mechanisms of action for new agents.
- Recall the latest data for new agents in development for GvHD and describe the rationale for selecting such treatments based on treatment- and patient-related factors.
- Explain how quality of life can be impacted in patients with GvHD and how this can be better managed in clinical practice.
GvHD Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy